Search research articles
Contact Us
Filters
Showing results (11-20 of 127) with videos related to
Page
of 13
Sort By:
International Journal of Colorectal Disease
|
May 30, 2003
Binding of gastrointestinal tumor cells to endothelial E- and P-selectin adhesion receptors leads to transient down-regulation of sLeX ligands in vitro
Horst Schuldes, Daniel Schleicher, Gottfried Mayer, et al.
Journal of Cellular and Molecular Medicine
|
July 29, 2008
The histone deacetylase inhibitor valproic acid alters growth properties of renal cell carcinoma in vitro and in vivo
Jon Jones, Eva Juengel, Ausra Mickuckyte, et al.
BJU International
|
July 15, 2009
Effects of combined valproic acid and the epidermal growth factor/vascular endothelial growth factor receptor tyrosine kinase inhibitor AEE788 on renal cell carcinoma cell lines in vitro
Eva Juengel, Johanna Engler, Ausra Mickuckyte, et al.
International Journal of Molecular Sciences
|
August 8, 2020
Bladder Cancer Metastasis Induced by Chronic Everolimus Application Can Be Counteracted by Sulforaphane In Vitro
Saira Justin, Jochen Rutz, Sebastian Maxeiner, et al.
World Journal of Urology
|
March 26, 2010
Maspin modulates adhesion of bladder carcinoma cells to vascular endothelium
Eva Juengel, Wolf-Dietrich C Beecken, Santhosh Mundiyanapurath, et al.
Nutrients
|
January 21, 2022
Olive Mill Wastewater Inhibits Growth and Proliferation of Cisplatin- and Gemcitabine-Resistant Bladder Cancer Cells In Vitro by Down-Regulating the Akt/mTOR-Signaling Pathway
Jochen Rutz, Sebastian Maxeiner, Eva Juengel, et al.
International Journal of Molecular Sciences
|
May 30, 2020
Curcumin-A Viable Agent for Better Bladder Cancer Treatment
Jochen Rutz, Andrea Janicova, Katja Woidacki, et al.
Experimental and Therapeutic Medicine
|
September 15, 2012
Valproate inhibits colon cancer growth through cell cycle modification in vivo and in vitro
Christoph W Strey, Lea Schamell, Elsie Oppermann, et al.
Plos One
|
January 4, 2013
Publication of original research in urologic journals--a neglected orphan?
Jens Mani, Jasmina Makarević, Eva Juengel, et al.
Plos One
|
February 2, 2013
Resistance after chronic application of the HDAC-inhibitor valproic acid is associated with elevated Akt activation in renal cell carcinoma in vivo
Eva Juengel, Jasmina Makarević, Igor Tsaur, et al.
Page
of 13
Search research articles
Search
Showing results (11-20 of 127) with videos related to
Sort By:
Page
of 13
International Journal of Colorectal Disease
|
May 30, 2003
Binding of gastrointestinal tumor cells to endothelial E- and P-selectin adhesion receptors leads to transient down-regulation of sLeX ligands in vitro
Horst Schuldes, Daniel Schleicher, Gottfried Mayer, et al.
Journal of Cellular and Molecular Medicine
|
July 29, 2008
The histone deacetylase inhibitor valproic acid alters growth properties of renal cell carcinoma in vitro and in vivo
Jon Jones, Eva Juengel, Ausra Mickuckyte, et al.
BJU International
|
July 15, 2009
Effects of combined valproic acid and the epidermal growth factor/vascular endothelial growth factor receptor tyrosine kinase inhibitor AEE788 on renal cell carcinoma cell lines in vitro
Eva Juengel, Johanna Engler, Ausra Mickuckyte, et al.
International Journal of Molecular Sciences
|
August 8, 2020
Bladder Cancer Metastasis Induced by Chronic Everolimus Application Can Be Counteracted by Sulforaphane In Vitro
Saira Justin, Jochen Rutz, Sebastian Maxeiner, et al.
World Journal of Urology
|
March 26, 2010
Maspin modulates adhesion of bladder carcinoma cells to vascular endothelium
Eva Juengel, Wolf-Dietrich C Beecken, Santhosh Mundiyanapurath, et al.
Nutrients
|
January 21, 2022
Olive Mill Wastewater Inhibits Growth and Proliferation of Cisplatin- and Gemcitabine-Resistant Bladder Cancer Cells In Vitro by Down-Regulating the Akt/mTOR-Signaling Pathway
Jochen Rutz, Sebastian Maxeiner, Eva Juengel, et al.
International Journal of Molecular Sciences
|
May 30, 2020
Curcumin-A Viable Agent for Better Bladder Cancer Treatment
Jochen Rutz, Andrea Janicova, Katja Woidacki, et al.
Experimental and Therapeutic Medicine
|
September 15, 2012
Valproate inhibits colon cancer growth through cell cycle modification in vivo and in vitro
Christoph W Strey, Lea Schamell, Elsie Oppermann, et al.
Plos One
|
January 4, 2013
Publication of original research in urologic journals--a neglected orphan?
Jens Mani, Jasmina Makarević, Eva Juengel, et al.
Plos One
|
February 2, 2013
Resistance after chronic application of the HDAC-inhibitor valproic acid is associated with elevated Akt activation in renal cell carcinoma in vivo
Eva Juengel, Jasmina Makarević, Igor Tsaur, et al.
Page
of 13